Schisandra chinensis (Turcz.) Baill. polysaccharide inhibits influenza A virus in vitro and in vivo
FEBS Open Bio · 2023
DOI: 10.1002/2211-5463.13690 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Jing Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Northeast Normal University, Changchun, China. Hauptthemen laut MEDLINE: Schisandra, Polysaccharides, Antiviral Agents, Influenza A virus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research & Development Program of China, Chinese National Natural Science Foundation.
Abstract (Originalsprache)
Influenza virus is prone to seasonal spread and widespread outbreaks, which pose important challenges to public health security. Therefore, it is important to effectively prevent and treat influenza virus infection. Schisandra polysaccharide (SPJ) is a polysaccharide derived from the fruit of Schisandra chinensis (Turcz.) Baill. In this study, we evaluated the antiviral activity of SPJ in vitro and in vivo , especially against influenza A virus (IAV) infection. By analyzing SPJ structure and monosaccharide composition, the molecular weight of SPJ was determined to be 115.5 KD, and it is composed of galacturonic acid (89.4%), rhamnose (0.8%), galactose (4.4%), arabinose (3.8%), and glucose (1.7%). Immunofluorescence analysis showed that SPJ treatment reduced the positive rate of viral nucleoproteins in cells, indicating that the compound had an inhibitory effect on influenza virus replication. Furthermore, SPJ therapy improved the survival of infected mice. Lung virus titer assays indicated that SPJ treatment significantly reduced viral loading in the lung tissue of infected mice and alleviated the pathological damage caused by influenza virus infection. Moreover, SPJ reduced cytokine expression during influenza virus challenge. In conclusion, SPJ has anti‐influenza virus effects and may have potential as an anti‐influenza drug candidate in further clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Northeast Normal University, Changchun, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China.
- The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, China.
- College of Life Sciences, Shandong Normal University, Jinan, China.
- College of Basic Medicine, Changchun University of Chinese Medicine, China.
ORCID-Profile: Tiecheng Wang
Förderung
- National Key Research & Development Program of China
- Chinese National Natural Science Foundation
Zitieren
APA
Qi, J., Lv, C., Guo, J., Li, Y., Sima, M., Luo, R., Xiang, H., Xia, X., Zhou, Y., & Wang, T. (2023). Schisandra chinensis (Turcz.) Baill. polysaccharide inhibits influenza A virus in vitro and in vivo. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13690
Vancouver
Qi J, Lv C, Guo J, Li Y, Sima M, Luo R, et al. Schisandra chinensis (Turcz.) Baill. polysaccharide inhibits influenza A virus in vitro and in vivo. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13690
BibTeX
@article{Qi2023,
author = {Qi, Jing and Lv, Chaoxiang and Guo, Jin and Li, Yuanguo and Sima, Mingwei and Luo, Rongbo and Xiang, Haiyang and Xia, Xianzhu and Zhou, Yifa and Wang, Tiecheng},
title = {Schisandra chinensis (Turcz.) Baill. polysaccharide inhibits influenza A virus in vitro and in vivo},
journal = {FEBS Open Bio},
year = {2023},
doi = {10.1002/2211-5463.13690}
}
EUVIMED